<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03902990</url>
  </required_header>
  <id_info>
    <org_study_id>20181443</org_study_id>
    <nct_id>NCT03902990</nct_id>
  </id_info>
  <brief_title>The Effect of Dual Tasking on Physical and Cognitive Functions in Patients With Parkinson Disease</brief_title>
  <official_title>Effects of Dual Task Training And Treadmill Training on Physical and Cognitive Functions in Patients With Parkinson Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ability of performing multi-tasking procedures is impaired in patients with Parkinson's
      disease. In this study, our goal was to detect the effects of dual-task training with
      treadmill training on walking and balance and to compare its effects on quality of life,
      cognitive functions and risk of fall, to treadmill training alone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">April 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>In this prospective, randomized, controlled, double-blinded study the patients were randomized to three groups as; dual-task group, single-task group and control group. All of the patients were scheduled on standard exercise programme. The patients in dual-task group received treadmill training with cognitive tasks and the patients in single-task group received treadmill training alone in addition to standard exercise programme. The training was scheduled as 30 minute sessions under supervision of a specialist, three times in a week for four weeks.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>10MWT</measure>
    <time_frame>12 weeks</time_frame>
    <description>10 Meter Walk Test on comfortable speed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>10MWT with cognitive tasks</measure>
    <time_frame>12 weeks</time_frame>
    <description>10 Meter Walk Test with cognitive tasks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MoCA</measure>
    <time_frame>12 weeks</time_frame>
    <description>Montreal Cognitive Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TUG</measure>
    <time_frame>12 weeks</time_frame>
    <description>Timed Up and Go Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PDQ-39</measure>
    <time_frame>12 weeks</time_frame>
    <description>Parkinson Disease Questionnaire 39</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FES-I</measure>
    <time_frame>12 weeks</time_frame>
    <description>To evaluate fear of falling, all patients filled the Falls Efficacy Scale-International (FES-I). A series of 16 questions assesses the respondent's fear of falling for a range of ADLs. Each question was rated on a four-point scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroop Test</measure>
    <time_frame>12 weeks</time_frame>
    <description>Cognitive assessment for executive functions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FOGQ</measure>
    <time_frame>12 weeks</time_frame>
    <description>Freezing of Gait Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Falls Diary</measure>
    <time_frame>4 weeks</time_frame>
    <description>Falls account</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Dual task</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treadmill training + cognitive tasks + standard exercise programme</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single task</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treadmill training + standard exercise programme</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard exercise programme</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dual task</intervention_name>
    <description>The patients in the dual task group received cognitive tasks during treadmill training sessions.</description>
    <arm_group_label>Dual task</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treadmill Training</intervention_name>
    <description>Standard treadmill training</description>
    <arm_group_label>Dual task</arm_group_label>
    <arm_group_label>Single task</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard exercise programme</intervention_name>
    <description>Standard exercise programme for Parkinson Disease</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Dual task</arm_group_label>
    <arm_group_label>Single task</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The patients with Idiopathic Parkinson Disease on medication who has

          -  Hoehn-Yahr 1-3

          -  Mini Mental Test score 20 and above

          -  Functional Ambulation Category 2 and above

          -  No changes in medication in last 3 months

          -  No rehabilitation programme in last 3 months

        Exclusion Criteria:

          -  Diagnosis of Parkinsonism other than Idiopathic Parkinson Disease

          -  Global aphasia

          -  Severe cognitive dysfunction

          -  Other neurologic/orthopedic diseases

          -  Limiting cardiovascular or pulmonary disease

          -  Visual impairment

          -  Hearing loss
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayse Yaliman, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Istanbul University Istanbul Faculty of Medicine Physical Medicine and Rehabilitation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ekin Ilke Sen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Istanbul University Istanbul Faculty of Medicine Physical Medicine and Rehabilitation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istanbul University Istanbul Faculty of Medicine Department of Physical Medicine and Rehabilitation</name>
      <address>
        <city>Istanbul</city>
        <state>Fatih</state>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Tugce Kocamal</investigator_full_name>
    <investigator_title>Assistant Doctor</investigator_title>
  </responsible_party>
  <keyword>dual task, treadmill, cognitive rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

